REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmaunio Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: PHARMAUNIO Gyogyszerkereskedelmi es Gyogyaszati Eszkozoket Forgalmazo Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Pharmaunio Bt. is a company in Hungary, with a head office in Tatabanya. It operates in the Pharmacies and Drug Stores industry. It was established on April 15, 1996. 10 (2024) employees currently work for Pharmaunio Bt.. In 2023, the company reported a net sales revenue increase of 7.02%. Its’ total assets recorded a growth of 1.37%. Pharmaunio Bt.’s net profit margin decreased by 1.41% in 2023.

Headquarters
Fo ter 30-A
Tatabanya; Komarom-Esztergom; Postal Code: 2800

Contact Details: Purchase the Pharmaunio Bt. report to view the information.

Website: http://www.smaragd-gyogyszertar.hu

Basic Information
Total Employees:
Purchase the Pharmaunio Bt. report to view the information.
Outstanding Shares:
Purchase the Pharmaunio Bt. report to view the information.
Registered Capital:
Purchase the Pharmaunio Bt. report to view the information.
Incorporation Date:
April 15, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pharmaunio Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.02%▲
Total operating revenue
6.73%▲
Operating profit (EBIT)
-20.8%▼
EBITDA
-17.07%▼
Net Profit (Loss) for the Period
-22.02%▼
Total assets
1.37%▲
Total equity
-8.94%▼
Operating Profit Margin (ROS)
-1.49%▼
Net Profit Margin
-1.41%▼
Return on Equity (ROE)
-5.97%▼
Quick Ratio
0.04%▲
Cash Ratio
0.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo